First Tracks Biotherapeutics, Inc. (TRAX)
First Tracks Biotherapeutics, Inc. (TRAX) is a Healthcare stock tracked by StreetAlpha. It last closed at $43.57 on Nov 17, down 6.42% on the day. TRAX reports earnings on Tue, Feb 2, 2027. The average 12-month price target from 5 analysts is $80.00 (+83.6% from the last close), with a high of $110.00 and a low of $60.00. Analyst consensus is Strong Buy, based on the latest ratings from 5 firms (5 buy, 0 hold, 0 sell).
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 5 analysts who set a price target on TRAX in the past 90 days. The average target is $80.00, with a high of $110.00 and a low of $60.00, compared with the last close of $43.57.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 4 | Guggenheim | Target raised | Buy | $100 → $110 |
| Oct 16 | Leerink Partners | Target raised | Buy | $46 → $90 |
| Oct 13 | Canaccord Genuity | Target raised | Buy | $50 → $60 |
| Oct 13 | Evercore ISI Group | Maintained | Buy | $70 |
| Oct 13 | Wells Fargo | Target raised | Buy | $55 → $70 |
Technical Analysis
The stock sits between its 20 and 50 day averages. Momentum is fading (RSI 48). The nearest support is the swing low (Nov 2) at $43.32, and the nearest resistance the Pivot at $44.45.
| RSI (14) | 48.11 | Middle of its range | Neutral |
| MACD | 2.18 | Below its signal line | Bearish |
| Stochastic | 22.1 | Middle of its range | Neutral |
| ADX (14) | 40.0 | Strong uptrend | |
| Williams %R | -95.7 | Oversold below −80, overbought above −20 | Oversold |
| CCI (20) | -59.1 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −6.0% | Change over 10 sessions | Bearish |
| ATR (14) | $3.27 | Typical daily range, 7.5% of price |
| RSI (14) | 59.46 | Middle of its range | Neutral |
| MACD | 6.37 | ||
| Stochastic | 70.7 | Middle of its range | Neutral |
| ADX (14) | 36.2 | Trending up | |
| Williams %R | -45.4 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 64.8 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +19.6% | Change over 10 sessions | Bullish |
| ATR (14) | $6.80 | Typical daily range, 15.6% of price |
What happened before
See how TRAX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90DNo whale options trades in TRAX in the last 90 days.
TRAX Institutional Ownership
Full report →- ▲117 buying vs 63 selling
- ▲Shares held by funds +10.2%
- ▲Funds holding +33
- ▲Superinvestors: 4 added, 0 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 182 | 149 | +22.1% |
| In funds' top 10 | 5 | 4 | +25.0% |
| Held by funds | – | – | – |
| New / increased | 50 / 67 | 148 / 0 | −20.9% |
| Reduced / sold out | 44 / 19 | 0 / 0 | – |
| Put/call ratio | 0.00 | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TRAX is in one of them and how their past TRAX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered TRAX in an article yet. Here's the latest on the wider market.



